Sample Informed Consent for Cash Pay Biologic Therapy

Sample informed consent documentation for cash pay biologic therapy procedures must explicitly disclose the regulatory classification of the tissue or cellular product, the clinical rationale, known procedural risks, and the patient's absolute financial responsibility due to lack of insurance coverage. Unlike standard procedural consents, self-pay regenerative forms require separated clinical and financial acknowledgments to protect the practice from billing disputes and regulatory scrutiny. Below is an operational framework and structural outline that medical practice managers can adapt with their healthcare compliance counsel.

Disclaimer: The following templates and checklists are provided for operational and educational reference only. They do not constitute legal advice. All clinical forms must be reviewed and approved by qualified healthcare legal counsel licensed in your state prior to clinical implementation.

Why Cash Pay Biologic Consents Require Specialized Structure

When a medical practice introduces self-pay regenerative service lines—such as platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), or Wharton’s Jelly and amniotic allografts—standard hospital-style surgical consents are rarely sufficient. Standard forms typically assume FDA premarket approval for any implanted material and rely on commercial payer medical necessity guidelines to frame the procedure.

In a cash-pay model, the administrative risk profile shifts. Practice managers must mitigate two distinct categories of risk: clinical liability (managing patient expectations around variable outcomes) and financial liability (preventing chargebacks, post-procedure refund demands, or allegations of deceptive marketing). Combining these elements into a well-structured intake packet ensures that patients understand both the biological nature of the biologics being utilized and the out-of-pocket nature of the transaction.

Core Components Checklist: Sample Informed Consent Documentation

When drafting or auditing your practice's sample informed consent documentation for cash pay biologic therapy procedures, ensure your healthcare attorney incorporates the following mandatory sections:

• Patient and Provider Identification: Full legal name of the patient, date of birth, the specific anatomical site(s) being treated, and the full name and credentials of the treating licensed clinician.
• Product Classification and Sourcing Disclosure: Clear identification of whether the biologic is autologous (harvested from the patient, such as PRP) or allogeneic (donor-derived tissue, such as umbilical cord blood, Wharton's Jelly, or MSC exosomes). State clearly how donor tissues are screened and processed by AATB-accredited tissue banks.
• Regulatory Status Acknowledgment: Explicit language stating that many regenerative biologic applications are considered investigational or off-label, and have not been evaluated or approved by the FDA to treat, cure, or prevent specific orthopedic, aesthetic, or systemic diseases.
• Procedure Description: A plain-language walkthrough of the clinical workflow, including blood draw or tissue preparation, local anesthesia, image guidance (if applicable, such as ultrasound or fluoroscopy), and the administration method.
• Material Risks and Potential Complications: Comprehensive listing of general procedural risks (infection, bleeding, nerve damage, localized pain, post-injection flare) and material-specific risks (allergic reaction, immunogenic response, or donor tissue transmission risks, however remote).
• No Guarantee of Clinical Outcome: A prominently placed, initialed clause confirming that biological responses vary by individual physiology, age, and pathology severity, and that complete symptom resolution cannot be promised.
• Viable Clinical Alternatives: Documentation that the patient was informed of conventional options, including conservative physical therapy, corticosteroid injections, pharmaceutical management, surgical intervention, or choosing no treatment at all.
• Financial Responsibility and Non-Coverage Waiver: Confirmation that the procedure is elective, not covered by Medicare, Medicaid, or commercial insurance, and that the patient agrees to pay the quoted fee in full prior to service delivery.

Sample Structural Language for Key Clauses

To assist practice administrators in preparing a draft for legal review, below are sample structural clauses addressing the most sensitive operational areas of cash-pay regenerative medicine.

1. Regulatory and Investigational Status Clause

"I understand that the biologic material being utilized in my procedure is regulated either as an autologous blood product or as a human cells, tissues, and cellular and tissue-based product (HCT/P). I acknowledge that while the preparation devices may be cleared by the FDA and donor tissues are processed in accordance with federal tissue bank regulations, the specific clinical application of these biologics for my condition may not be specifically approved by the FDA. I am electing to undergo this procedure voluntarily based on my consultation with my physician."

2. Expectation Management and No-Warranty Clause

"I acknowledge that regenerative medicine procedures rely on complex biological signaling and tissue remodeling processes that vary significantly from patient to patient. No guarantees, warranties, or assurances have been made to me regarding the success of this procedure, the degree of pain relief, or the timeline of functional recovery. I understand that multiple sessions or adjunct therapies (such as shockwave therapy or physical rehabilitation) may be recommended to optimize my clinical response, and that there is a possibility my symptoms may not improve."

3. Self-Pay Financial Agreement and Waiver of Billing

"I have been informed that this biologic therapy procedure is classified as elective, investigational, or not medically necessary by commercial health insurance carriers and government payers (including Medicare and Medicaid). I understand that the practice will not submit a claim to my insurance carrier for this service, nor will it provide diagnostic codes designed to secure reimbursement for non-covered biologics. I accept full, personal financial responsibility for the total cost of the procedure as outlined in my signed treatment estimate. I understand that once the biologic product is prepared, thawed, or administered, fees are non-refundable regardless of my subjective clinical outcome."

Clinical Considerations for Treating Physicians

While practice managers manage the documentation workflow, the legal validity of informed consent depends entirely on the treating physician's clinical communication. Informed consent is an ongoing clinical dialogue, not merely a signature on an iPad in the waiting room.

For physicians across orthopedics, pain management, and aesthetics, the chart note must corroborate the signed consent form. Clinicians should dictate or utilize an EHR macro confirming that they personally reviewed the diagnostic imaging, explained the mechanism of action of the selected biologic or adjunct devices, discussed surgical and conservative alternatives, and gave the patient an opportunity to ask questions.

Furthermore, clinicians must ensure that their verbal explanations align strictly with the written consent. If a consent form properly avoids promising cartilage regeneration or guaranteed tissue regrowth, the clinical staff and physician must maintain that same disciplined terminology during the consultation.

Operational Workflow: Integrating Consents with Traceability

From a practice management perspective, executing the informed consent is only half of the compliance workflow. When utilizing allografts or exosomes, the signed consent must be paired with rigorous inventory traceability in the Electronic Health Record (EHR).

1. Pre-Visit Delivery: Send the clinical informed consent and the separate financial ABN/self-pay agreement via the patient portal at least 48 hours before the scheduled procedure. This eliminates claims that the patient felt pressured to sign under duress or after pre-procedure analgesia was administered.
2. Day-of-Procedure Verification: The medical assistant or nurse verifies that all individual clauses are initialed prior to thawing any cryopreserved allograft or drawing blood for PRP.
3. Lot Number and Tissue Tracking: Attach the manufacturer’s peel-off lot sticker directly to the physical consent form (if scanning paper) or scan the barcode directly into the EHR implant log linked to that specific encounter. Ensure the tissue tracking card is returned to the distributor or tissue bank to maintain a complete chain of custody.

What This Means for Your Practice

Standardizing your informed consent and financial waiver documentation reduces administrative friction, protects your merchant processing accounts from disputes, and establishes a defensible compliance posture. Practice managers implementing or auditing a biologic service line should take the following concrete next steps:

• Separate Clinical and Financial Forms: Ensure patients sign two distinct documents—a clinical informed consent detailing medical risks, and a financial agreement detailing exact pricing, package terms, and refund policies.
• Audit Marketing vs. Consent Alignment: Review your practice website, brochures, and intake scripts to ensure your promotional language does not contradict the disclaimers in your legal consent packet.
• Verify Vendor Documentation: Partner only with licensed medical distributors that provide complete regulatory packets, Certificates of Analysis (COAs), and tissue tracking logs for every biologic unit ordered.
• Engage Healthcare Counsel: Submit your updated draft templates to a state-licensed healthcare attorney to verify compliance with state-specific statutes regarding stem cell and regenerative therapy disclosures (such as specific statutory notice requirements in states like Texas or California).

If your practice is evaluating compliant biologic sourcing, device integration, or operational workflows for regenerative medicine, contact the team at Dallas Regenerative Solutions to schedule a consultation with a dedicated account specialist.